XML 142 R50.htm IDEA: XBRL DOCUMENT
v3.24.1

(LOSSES)/GAINS ON DERIVATIVE INSTRUMENTS AND OTHER FINANCIAL ITEMS, NET (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative instruments, gain (loss) | (Losses)/gains on derivative instruments, net is comprised of the following:
| Year Ended December 31,
(in thousands of $) | 2023 | 2022 | 2021
Unrealized MTM adjustment for interest rate swap (“IRS”) derivatives | (15,583) |  | 72,269 |  | 27,016 |
Net interest income/(expense) on undesignated IRS derivatives | 8,356 |  | (772) |  | (2,908) |
Foreign exchange gain on terminated undesignated foreign exchange swaps | — |  | — |  | 240 |
(Losses)/gains on derivative instruments, net | (7,227) |  | 71,497 |  | 24,348 |
Components of other financial items, net | Other non-operating (loss)/income, net is comprised of the following:
| Year Ended December 31, |  |
(in thousands of $) | 2023 | 2022 | 2021 |  |
Dividend income from our investment in listed equity securities | 9,823 |  | 4,768 |  | 5,588 |  |  |
UK tax lease liability (1) | — |  | 7,148 |  | (71,739) |  |  |
Realized and unrealized MTM (losses)/gains on our investment in listed equity securities (note 16) (2) | (62,308) |  | 400,966 |  | (295,777) |  |  |
Others | — |  | — |  | 124 |  |  |
Other non-operating (loss)/income | (52,485) |  | 412,882 |  | (361,804) |  |  |
(1) In April 2022, we settled our liability to the UK tax authority in relation to former leasing arrangements of $66.4 million, inclusive of fees and released the remaining UK tax lease liability of $5.3 million and recognized a foreign exchange movement of $1.8 million. (2) “Investment in listed equity securities”, included in balance sheet line-item “Other current assets” (note 16), relates to our equity holding in NFE of nil and 5.3 million shares as of December 31, 2023 and 2022, respectively. During the years ended December 31, 2023, 2022 and 2021, we recognized $nil, $350.9 million unrealized MTM gains and $295.8 million unrealized MTM losses, respectively. In 2023 and 2022, we sold 1.2 million and 13.3 million of our NFE Shares at a price range between $36.90 and $40.38 per share and $40.80 and $58.29 per share for an aggregate consideration of $45.6 million and $625.6 million which resulted to $62.3 million realized MTM losses, $50.1 million realized MTM gains, respectively. There was no comparable sale of our NFE Shares during the year ended December 31, 2021. On March 15, 2023, we disposed of our remaining 4.1 million NFE Shares that were applied as partial consideration for the repurchase of 1,230 Hilli common from NFE, which NFE acquired pursuant to the sale of our investment in Golar Partners to NFE in April 2021. Following these transactions, we no longer hold any listed equity securities. Other financial items, net is comprised of the following:
| Year Ended December 31,
(in thousands of $) | 2023 | 2022 | 2021
Financing arrangement fees and other related costs (1) | (1,667) |  | (9,340) |  | (1,201) |
Amortization of debt guarantees | 2,019 |  | 2,657 |  | 2,569 |
Foreign exchange (loss)/gain on operations | (941) |  | 1,598 |  | (384) |
Other | (311) |  | (295) |  | (291) |
Other financials items, net | (900) |  | (5,380) |  | 693 |
(1) Financing arrangement fees and other related costs for the year ended December 31, 2022 is mainly comprised of (i) $4.9 million write-off of deferred financing fees and expenses in relation to an undrawn corporate bilateral facility, the availability of which expired in June 2022; (ii) $2.3 million loss on partial repurchase of our $300.0 million senior unsecured bonds (“Unsecured Bonds”) in December 2022 (note 21); and (iii) $1.4 million commitment fees paid in relation to the undrawn portion of the Corporate RCF, which was canceled in November 2022 (note 21).

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items. + References No definition available. + Details
Name: | us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration